Related Citations for PubMed (Select 19591638) - PubMed

<< First< Prev

Page of 6

Next >Last >>

Results: 1 to 20 of 101

Predicting the future of anti-tumor necrosis factor therapy.

Verweij CL.

Arthritis Res Ther. 2009;11(3):115. Epub 2009 Jun 22.

PMID:: 19591638; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis.

Hueber W, Tomooka BH, Batliwalla F, Li W, Monach PA, Tibshirani RJ, Van Vollenhoven RF, Lampa J, Saito K, Tanaka Y, Genovese MC, Klareskog L, Gregersen PK, Robinson WH.

Arthritis Res Ther. 2009;11(3):R76. Epub 2009 May 21.

PMID:: 19460157; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.

Ranganathan P.

Pharmacogenomics. 2005 Jul;6(5):481-90. Review.

PMID:: 16013998; [PubMed - indexed for MEDLINE]

Related citations

[Current aspects of cost effectiveness of TNF-alpha blocking agents in patients with rheumatoid arthritis].

Merkesdal S, Ruof J.

Z Rheumatol. 2002;61 Suppl 2:II/29-32. Review. German.

PMID:: 12491120; [PubMed - indexed for MEDLINE]

Related citations

Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.

Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A.

Isr Med Assoc J. 2008 Apr;10(4):277-81.

PMID:: 18548981; [PubMed - indexed for MEDLINE]

Free Article

Related citations

Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.

Hyrich KL, Lunt M, Watson KD, Symmons DP, Silman AJ; British Society for Rheumatology Biologics Register.

Arthritis Rheum. 2007 Jan;56(1):13-20.

PMID:: 17195186; [PubMed - indexed for MEDLINE]

Free Article

Related citations

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.

Coenen MJ, Toonen EJ, Scheffer H, Radstake TR, Barrera P, Franke B.

Pharmacogenomics. 2007 Jul;8(7):761-73.

PMID:: 17638513; [PubMed - indexed for MEDLINE]

Related citations

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

PMID:: 11961174; [PubMed - indexed for MEDLINE]

Free Article

Related citations

Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade.

Manadan AM, Block JA.

Am J Ther. 2008 Jan-Feb;15(1):53-8. Review.

PMID:: 18223354; [PubMed - indexed for MEDLINE]

Related citations

10.

[New drugs and treatment strategies for rheumatoid arthritis].

Fantini F.

Recenti Prog Med. 2003 Sep;94(9):361-79. Review. Italian.

PMID:: 12942798; [PubMed - indexed for MEDLINE]

Related citations

11.

Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.

Nurmohamed MT, van Halm VP, Dijkmans BA.

Drugs. 2002;62(11):1599-609. Review.

PMID:: 12109923; [PubMed - indexed for MEDLINE]

Related citations

12.

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.

Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, Bertilsson L, Cöster L, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, van Vollenhoven R, Klareskog L, Feltelius N.

Ann Rheum Dis. 2009 May;68(5):648-53. Epub 2008 May 8.

PMID:: 18467516; [PubMed - indexed for MEDLINE]

Related citations

13.

Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.

Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M.

Arthritis Res Ther. 2005;7(2):R250-5. Epub 2005 Jan 10.

PMID:: 15743471; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

14.

CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis.

Stuhlmüller B, Häupl T, Hernandez MM, Grützkau A, Kuban RJ, Tandon N, Voss JW, Salfeld J, Kinne RW, Burmester GR.

Clin Pharmacol Ther. 2010 Mar;87(3):311-21. Epub 2009 Dec 23.

PMID:: 20032971; [PubMed - indexed for MEDLINE]

Related citations

15.

Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.

Flendrie M, Vissers WH, Creemers MC, de Jong EM, van de Kerkhof PC, van Riel PL.

Arthritis Res Ther. 2005;7(3):R666-76. Epub 2005 Apr 4.

PMID:: 15899052; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

16.

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.

PMID:: 16705046; [PubMed - indexed for MEDLINE]

Free Article

Related citations

17.

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.

Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.

Arthritis Rheum. 2007 May;56(5):1417-23.